Trials / Conditions / Unresectable Extrahepatic Bile Duct Carcinoma

Unresectable Extrahepatic Bile Duct Carcinoma

6 registered clinical trials studyying Unresectable Extrahepatic Bile Duct Carcinoma.

Status	Trial	Sponsor	Phase
Completed	Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnos NCT03768414	SWOG Cancer Research Network	Phase 3
Withdrawn	Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Ch NCT02856568	Mayo Clinic	Phase 1
Completed	Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Bili NCT02392637	M.D. Anderson Cancer Center	Phase 2
Completed	Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder NCT02042443	National Cancer Institute (NCI)	Phase 2
Completed	MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery NCT01425879	National Cancer Institute (NCI)	Phase 2
Completed	Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Me NCT01093222	National Cancer Institute (NCI)	Phase 2